Association between single nucleotide polymorphisms in the Cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma

OMICS A Journal of Integrative Biology

Volumn 15, Issue 3, 2011, Pages 193-196

  Giacalone, Antonio ^a   Montalto, Giuseppe ^a   Giannitrapani, Lydia ^a   Balasus, Daniele ^b   Terranova, Angela ^a   Cervello, Melchiorre ^c   Soresi, Maurizio ^a   Marasà, Lorenzo ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b ARNAS Civic Hospital   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, HEPATOCELLULAR; CYCLOOXYGENASE 2; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIVER NEOPLASMS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952525565     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2010.0095     Document Type: Article

References (26)

1. Assy, N., Paizi, M., Gaitini, D., Baruch, Y., and Spira, G. (1999). Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 5, 296-300.
2. Ataseven, H., Bahcecioglu, I. H., Kuzu, N., Yalniz, M., Celebi, S., Erensoy, A., et al. (2006). The levels of Ghrelin, Leptin, TNF-a, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Med Inflam 2006, 1-6.
3. Benjamin, M. N., and Pak, C. S. (2004). The future of association studies: gene-based analysis and replication. Am J Hum Genet 75, 353-362.
4. Carmeliet, P., and Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature 407, 249-257.
5. Dikov, M. M., Ohm, J. E., Ray, N, Tchekneva, E. E., Burlison, J., Moghanaki, D., et al. (2005). Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 174, 215-222. (Pubitemid 40007407)
6. El-Serag, H. B., and Rudolph, K. L. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576. (Pubitemid 46890874)
7. Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C, Oudard, S., Siebels, M., et al. (2007). Sorafenib in advanced clear-cell renalcell carcinoma. N Engl J Med 356, 125-134. (Pubitemid 46089673)
8. Ghosh, J., Joshi, G, Pradhan, S., and Mittal, B. (2010). Investigation of TNFA 308G > A and TNFB 252G > A polymorphisms in genetic susceptibility to migraine. J Neurol 257, 898-904.
9. Hajeer, A. H., and Hutchinson I. V. (2001). Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 62, 1191-1199. (Pubitemid 33032271)
10. Han, S. W., Kim, G. W., Seo, J. S., Kim, S. J., Sa, K. H., Park, J. Y., et al. (2004). VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 43, 1173-1177. (Pubitemid 39232824)
11. Jinno, K, Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Doi, T., et al. (1998). Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol 33, 376-382. (Pubitemid 28263653)
12. Kong, S. Y., Park, J. W., Lee, J. A., Park, J. E., Park, K. W., Hong, E. K., et al. (2007). Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients. Hepatology 46, 446-455.
13. Kroeger, K. M., Steer, J. H., Joyce, DA., Abraham, L. J. (2000). Effects of stimulus and cell type on the expression of the-308 tumour necrosis factor promoter polymorphism. Cytokine 12, 110-119. (Pubitemid 30449863)
14. Liu, J. G, Zhao, H. J., Liu, Y. J., and Wang, X. L. (2010). Effect of selenium-enriched malt on VEGF and several relevant angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J Trace Elem Med Biol 24, 52-57.
15. Liu, L. F., Zhang, J. L., Chen, Q., and Chang, Y. L. (2010). Cyclooxygenase-2 gene - 1195G/A genotype is associated with the risk of HBV-induced HCC: a case-control study in Han Chinese people. Front Med China 4, 90-95.
16. Majno, G (1998). Chronic Inflammation. Am J Pathol 153, 1035-1039.
17. Montalto, G, Cervello, M., Giannitrapani, L., Dantona, F., Terranova, A., Castagnetta L. A., et al. (2002). Epidemiology, risk factors and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 963, 13-20. (Pubitemid 34721691)
18. Pang, R, and Poon, RT. (2006). Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 242, 151-167. (Pubitemid 44485315)
19. Panguluri, R. C., Long, L. O., Chen, W., Wang, S., Coulibaly, A., Ukoli, F., et al. (2004). COX-2 gene promoter haplotypes and prostate cancer risk. Carcinogenesis 25, 961-966. (Pubitemid 38886082)
20. Perrey, C, Turner, S. J., Pravica, V., Howell, W. M., and Hutchinson, I. V. (1999). ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transplant Immunol 7, 127-128. (Pubitemid 29472075)
21. Pugh, C. W., and Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9, 677-684. (Pubitemid 36749216)
22. Renner, W., Kotschan, S., Hoffmann, C, Obermayer-Pietsch, B., Pilger, E. (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37, 443-448. (Pubitemid 32037619)
23. Schwartz, M., Roayaie, S., and Konstadoulakis, M. (2007). Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 4, 424-432. (Pubitemid 47039693)
24. Sfar, S., Hassen, E., Saad, H., Mosbah, F., and Chouchane, L. (2006). Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35, 21-28. (Pubitemid 44485531)
25. Soresi, M., La Spada, E., Giannitrapani, L., Campagna, E., Di Gesaro, V., Granà, W., et al. (2010). Hepatocellular carcinoma: comparison of two different periods at the same center. Eur J Intern Med 21, 127-130.
26. Watson, C. J., Webb, N. J., Bottomley, M. J., Brenchley, P. E. (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12, 1232-1235. (Pubitemid 30611801)